Plain-English translation of NCT07459296 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , a newer type of cancer-fighting medication combined with (an immunotherapy drug), works better than the standard chemotherapy approach for people with advanced nasopharyngeal cancer. All participants will also receive radiation therapy. The goal is to see if this new combination can help more people survive longer without their cancer returning.
Advanced nasopharyngeal cancer is a serious condition, and doctors want to find better treatment options. This medication combination represents a newer approach that may be more effective than the standard chemotherapy regimen that has been used for many years.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two treatment groups. Both groups receive radiation therapy to the throat area. One group receives the newer medication combination ( plus ) followed by radiation and additional ; the other receives standard chemotherapy followed by radiation. The entire treatment lasts several months, and you will have regular clinic visits for blood tests, scans, and check-ups. The study team will monitor you closely for side effects and how well the treatment is working.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China